SUSTAINED RELEASE OF APO A-I MIMETIC PEPTIDES AND METHODS OF PRODUCING THEM
    8.
    发明申请
    SUSTAINED RELEASE OF APO A-I MIMETIC PEPTIDES AND METHODS OF PRODUCING THEM 审中-公开
    APO A-I模拟肽的持续释放及其生产方法

    公开(公告)号:WO2009070211A1

    公开(公告)日:2009-06-04

    申请号:PCT/US2008/012794

    申请日:2008-11-14

    CPC classification number: A61K31/661 A61K9/1647 A61K9/5084 A61K38/00

    Abstract: A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.

    Abstract translation: 一种方法,包括使递送装置通过血管腔推进到血管中的特定区域; 并且将包含缓释载体和载脂蛋白AI(apo AI)合成模拟肽的组合物引入血管的特定区域或血管周围部位的壁中,其中所述肽具有使肽有效反转的性质 胆固醇运输。 以适合递送到血管中的形式包含载脂蛋白AI(apo AI)合成肽或者apo AI合成模拟肽和酰基CoA胆固醇:酰基转移酶(ACAT)抑制剂的组合物,所述肽包括氨基酸 序列的顺序与各种apo AI模拟肽或内源性apo AI类似物或内源性apo AI的螺旋1和螺旋9的嵌合体的顺序相反。

    SUSTAINED RELEASE OF APO A-I MIMETIC PEPTIDES AND METHODS OF TREATMENT
    9.
    发明申请
    SUSTAINED RELEASE OF APO A-I MIMETIC PEPTIDES AND METHODS OF TREATMENT 审中-公开
    可持续发布的APO A-I型胶原蛋白和治疗方法

    公开(公告)号:WO2009070209A2

    公开(公告)日:2009-06-04

    申请号:PCT/US2008/012767

    申请日:2008-11-14

    Abstract: A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.

    Abstract translation: 一种方法,包括使输送装置通过血管的内腔前进到血管中的特定区域; 并将包含持续释放载体和载脂蛋白AI(apo AI)合成模拟肽的组合物引入所述特定区域或血管周围部位的血管壁中,其中所述肽具有使所述肽有效反转的性质 胆固醇运输。 包含载体载脂蛋白AI(apo AI)合成肽或apo AI合成模拟肽和Acyl CoA胆固醇:酰基转移酶(ACAT)抑制剂的组合的组合物,其形式适于递送到血管中,所述肽包含氨基酸 序列以与各种apo AI模拟肽或内源性载脂蛋白AI类似物的顺序相反的顺序,或内源性apo AI的螺旋1和螺旋9的嵌合体。

Patent Agency Ranking